Harbor Therapeutics
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of the Safety, Tolerance and Assessment of HE3286 on Insulin Sensitivity and Hepatic Glucose Production (NCT00991107) | Harbor Therapeutics | 2009-09-01 |
| Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid Arthritis (NCT00712114) | Harbor Therapeutics | 2008-07-01 |
| A Phase I/II Study of HE3235 in Patients With Prostate Cancer (NCT00716794) | Harbor Therapeutics | 2008-07-01 |
| Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes Mellitus (NCT00694057) | Harbor Therapeutics | 2008-06-01 |
| Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis (NCT00628433) | Harbor Therapeutics | 2008-02-01 |
| Safety, Pharmacokinetics and Potential Activity of HE3286 in Obese Adult Subjects (NCT00555451) | Harbor Therapeutics | 2007-10-01 |
| A Study on the Safety and Anti-HIV Activity of HE2000 in HIV-Infected Patients on Salvage Therapy (NCT00002422) | Harbor Therapeutics |
Track Harbor Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.